Ondansetron Injection, Solution
Product Images NDC 76045-216

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 76045-216). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ond06 0008 01)

Chemical structure of ondansetron hydrochloride dihydrate, illustrating the molecular framework of the active pharmaceutical ingredient. The structure includes a fused ring system, a methylated nitrogen, and a substituted imidazole ring with the hydrochloride and water of hydration indicated.*

FDA Label Image

Figure 1 (Ond06 0008 02)

An instructional diagram showing components of a prefilled syringe for Ondansetron injection, solution. Labeled parts include the outer package, plunger rod, syringe barrel, label (marked 'Do not remove'), luer lock collar (marked 'Do not remove'), and syringe tip cap.*

FDA Label Image

Figure 2 (Ond06 0008 03)

An instructional illustration showing two hands opening a blister pack containing a prefilled syringe for injection. The image demonstrates the step of peeling back the protective cover to access the syringe inside.*

FDA Label Image

Figure 3 (Ond06 0008 04)

An instructional illustration showing hands removing a cap from a vial or ampule, indicated by a curved arrow pointing counterclockwise. This diagram likely demonstrates the first step in preparing an injection.*

FDA Label Image

Fresenius Kabi Logo (Ond06 0008 05)

ONDASETRON injection solution 4 mg/2 mL label from Fresenius Kabi USA, LLC. The label shows product name and strength, administration routes including intramuscular and intravenous, with a clean, primarily white and blue design, and Fresenius Kabi USA LLC branding.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Packaging label for Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL) solution for injection by Fresenius Kabi USA, LLC. The label indicates the product contains 24 prefilled single-use 2 mL syringes intended for intravenous or intramuscular use. The label includes usage warnings and storage instructions.*

FDA Label Image

Package Label – Principal Display (Ondansetron 2 mL Blister Pack Label)

Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) in a 2 mL prefilled single use syringe for intravenous or intramuscular use. The label includes cautionary information for chemotherapy-induced nausea and vomiting, storage instructions, and dosage guidelines. Manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Label for Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) solution for injection by Fresenius Kabi USA, LLC. The label includes a volume scale from 0.5 to 2 mL marked for single use via intravenous or intramuscular routes. It also displays a barcode, a prescription-only designation, and a red warning that dilution is required for chemotherapy-induced nausea and vomiting.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ondansetron 2 mL Carton Panel)

Packaging label for Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) solution for injection. The label states the drug is for intravenous or intramuscular use and contains 24 prefilled single-use syringes of 2 mL each. The product is labeled by Fresenius Kabi USA, LLC and includes handling instructions and barcodes.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ondansetron 2 mL Blister Pack Label)

Ondansetron Injection USP 4 mg/2 mL (2 mg/mL) in a 2 mL prefilled single-use syringe by Fresenius Kabi USA, LLC. Label includes dosing route for intravenous or intramuscular use, storage instructions, and a caution notice for chemotherapy-induced nausea and vomiting. The package displays the NDC 76045-103-00 and has a barcode with lot and expiration placeholders.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY - Ondansetron 2 mL Syringe Label)

Label of Ondansetron Injection, USP 4 mg/2 mL (2 mg/mL) solution for injection by Fresenius Kabi USA, LLC. The label indicates use for intravenous (IV) or intramuscular (IM) route and specifies 2 mL single use. A barcode and a red box note stating "Dilution required for chemotherapy induced nausea and vomiting" are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.